ASH’s New Guidelines for AYA ALL, FDA’s Actions on Lorigerlimab and SRN-101, and Updates on Melanoma & Multiple Myeloma Treatments

Discover latest updates in medical sector including ASHs guidelines for AYA Acute Lymphoblastic Leukemia, FDAs hold on Lorigerlimab trial, SRN-101s…

Breakthroughs in Nutritional Science, Plant-Based Foods, Novelities in In-Vitro Neurotoxicity, and Strategies for Antimicrobial Resistance

Explore cutting-edge research in nutrition, food technology, neuroscience, and microbiology. Contributions from Gabi Saavedra, Dr Lena Smirnova, and Natasha Bury.